# David García

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-garcia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,324 |
| Field | Venous Thromboembolism Diagnosis and Management |
| h-index | 62 |
| i10-index | 142 |
| Last Known Institution | University of Washington |
| OpenAlex ID | https://openalex.org/A5100766043 |
| ORCID iD | https://orcid.org/0000-0002-7820-050X |
| Works | 341 |

## Researcher papers

- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer](https://scholariq.org/papers/rivaroxaban-for-thromboprophylaxis-in-high-risk-ambulatory-patients-with-cancer/)
- [The 2023 <scp>ACR</scp>/<scp>EULAR</scp> Antiphospholipid Syndrome Classification Criteria](https://scholariq.org/papers/the-2023-scp-acr-scp-scp-eular-scp-antiphospholipid-syndrome-classification/)
- [2023 ACR/EULAR antiphospholipid syndrome classification criteria](https://scholariq.org/papers/2023-acr-eular-antiphospholipid-syndrome-classification-criteria/)
- [Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment](https://scholariq.org/papers/guidance-for-the-practical-management-of-the-direct-oral-anticoagulants-doacs-in/)
- [Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis](https://scholariq.org/papers/direct-oral-anticoagulant-doac-versus-low-molecular-weight-heparin-lmwh-for/)
- [Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial](https://scholariq.org/papers/apixaban-for-patients-with-atrial-fibrillation-on-hemodialysis-a-multicenter/)

## Researcher topics

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)

## Researcher university

- [University of Washington](https://scholariq.org/institutions/university-of-washington/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
